Merck & Co., Inc. Announced Q1 2026 Earnings on April 30, 2026, Reporting "revenue of $16.3 billion" for the quarter.
Merck & Co. announced Q1 2026 earnings, reporting $16.3 billion in revenue, a 5% increase. Key developments included a partnership with Google Cloud, the FDA approval of IDVYNSO, and sales highlights for KEYTRUDA, WINREVAIR, and GARDASIL. The company also provided updated…